Radiopharmaceuticals/Nuclear Medicine is a specialized field of medicine that covers all aspects of use of radioactive substances which are used for diagnosis or treatment of various diseases such as cancers, cardiovascular dise ....see more
The global nuclear medicine market, valued at US$9.03 billion in 2024, stood at US$10.41 billion in 2025 and is projected to advance at a resilient CAGR of 15.1% from 2025 to 2030, culminating in a forecasted valuation of US$21.01 billion by the end of the period. The growth of the market is driven by the rising prevalence of cancer and cardiovascular diseases, which is accelerating the demand for diagnostic and therapeutic radiopharmaceuticals and medical radioisotopes.